Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial.
Lancet Respir Med
; 9(10): 1130-1140, 2021 10.
Article
in En
| MEDLINE
| ID: mdl-34252378
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Patient Admission
/
Azithromycin
/
COVID-19 Drug Treatment
/
Anti-Infective Agents
Type of study:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Lancet Respir Med
Year:
2021
Type:
Article